Mariner
MJN

Mariner’s Mead Johnson Nutrition Company MJN Stock Holding History

Mariner’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-5,783
Closed -$409K – 617
2016
Q4 		$409K Sell
5,783
-2,724
-32% -$203K 0.02% 399
2016
Q3 		$671K Sell
8,507
-376
-4% -$32.1K 0.03% 321
2016
Q2 		$806K Sell
8,883
-6,810
-43% -$577K 0.04% 272
2016
Q1 		$1.33M Buy
15,693
+4,188
+36% +$312K 0.08% 207
2015
Q4 		$908K Sell
11,505
-290
-2% -$22.8K 0.06% 225
2015
Q3 		$830K Sell
11,795
-5,679
-32% -$467K 0.04% 271
2015
Q2 		$1.58M Sell
17,474
-186
-1% -$17.9K 0.07% 203
2015
Q1 		$1.77M Buy
17,660
+57
+0.3% +$5.75K 0.15% 114
2014
Q4 		$1.77M Buy
17,603
+332
+2% +$33.1K 0.16% 114
2014
Q3 		$1.66M Buy
17,271
+326
+2% +$30.9K 0.19% 98
2014
Q2 		$1.58M Buy
16,945
+1,175
+7% +$103K 0.18% 112
2014
Q1 		$1.31M Buy
+15,770
New +$1.28M 0.17% 123

Other funds holding MJN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $20.5B AUM 26.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Mariner's MJN Position: Q1 2017 in Review

Mariner sold out of Mead Johnson Nutrition Company (MJN) in Q1 2017, closing a stake of 5,783 shares — an estimated $409K sold.

Mariner first reported a position in MJN in Q1 2014 and held it in 12 quarters. The position peaked at $1.77M in Q1 2015. 533 funds tracked by Wall St. Rank hold MJN as of Q1 2017.

  • Mariner reported no remaining Mead Johnson Nutrition Company position as of Q1 2017 after selling out during the quarter.
  • Mariner sold 5,783 Mead Johnson Nutrition Company shares in Q1 2017, an estimated $409K.
  • Mariner first reported a position in Mead Johnson Nutrition Company in Q1 2014 and held it in 12 quarters.
  • Mariner's Mead Johnson Nutrition Company position peaked at $1.77M in Q1 2015.
  • 533 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q1 2017.

Based on Mariner's 13F filing for Q1 2017, filed 15 May 2017.